Prediction Time: Will The Offer Be Increased And By How Much

I do not see them offering more with the deal not being hostile and no longer in negotiations, rather accepted unanimously by OCAT.

Will SH's force a vote?

I want out before legal action filed.

i believe sh will force a vote but that institutional investors will vote for a nice gain on there investment of just months ago and getting 50.001 percent will be attained by mgt. No reason for them to up the pps as even if they do there will be someone suing them, In my opinion the cost of a lawsuit with ten plaintiffs or a hundred makes no difference to them. the lawyers will take a multi million dollar settlement, pay themselves a fortune and the crumbs to the plaintiffs. the lawsuit takes place after the deal goes through so no need to worry about damages to ocata or getting the 850 pps. Also, There is a very slim chance another bid could come into play at the eleventh hour. If i anm wrong, some one could correct me. imo glta

Time to wake up and realize that we are seeing what the insiders have seen for a long time.

For as awesome as we have wanted this to be, it just didn't turn out that way.

This company and science is finished and is going to be shelved and used the way the new owners want it to be used.

Cures don't make money, drugs make money.

If there was anything more than we have seen in this offer it would have already shown up a long time ago.

The company proved this when the road trip failed to get even $5 a share. The only thing that has kept this company alive is the hopeful retail investors and any institutions that have sold for a profit.

Seems kind of obvious to me that what rickrick meant is that ongoing repeat treatments will generate more revenue than a one-off cure.

But what Rickrick said was that cures do not make money. 

While there may not be as much revenue to gain in removing an ailment, to conflate that with the idea that there is NO money in removing the ailment is not an accurate assessment. Cures can make you money because there will continue to be a fresh pool of patients requiring your [ideally] one-off treatment. 

And if a cure for your disease exists, you'd damn well BETTER be the one who discovered it, because your treatment is going to be phased out by the competition. There is major, major incentive to identify better treatments in drug development. 

And for most diseases, especially degenerative conditions, there is no cure, and there may never be. 

This poll locks up at the end of the business day and it looks like the nays have it. Happy Thanksgiving to all, I hope your turkey turns out better than this investment.

Today and recent days trading taking place above the $8.50 tender offer is a bullish sign that there a)another bidder b)Astella will be forced to increase their offer.

If there is another bidder i.e. (Company B) there is no telling what will happen. I am of course anticipating a higher bid.

Here is an interesting quick read. 

May 17,2015
cashtenderoffer.com/

In a cash tender offer, cash is offered to company stockholders in exchange for their shares. These deals can offer investors attractive returns.

Investing in cash tender offers can be rewarding indeed. According to a published article, investors would have turned $10,000 into $70,600 from 1981 to 1995 by buying the target company’s shares a day after the announcement and holding until the deal closed. The same amount invested in the stock market would have grown to $31,400. While these results are impressive, there could be periods when you’d lose money. And, there’s no guarantee this strategy will work in the future.

Acquirers include hedge funds, private equity, management led investor groups, and other corporations. The day after the announcement, the target company’s shares often trade below or at a “discount” to the offer price. The size of the discount reflects the uncertainty and time to completion of the deal. As the closing date nears and concerns about the deal are resolved, this spread usually narrows. In part, it’s the increase in share price between the day after the announcement until the closing date that offers the potential for gains. If the discount widens, then perhaps there’s trouble afoot. The deal price could be lowered or worse, the deal could fall apart altogether.

Occasionally, the target company’s shares will trade above or at a “premium” to the offer price. This is generally an indication that arbitrageurs expect the offer to be increased. Perhaps shareholders intend to resist the bid because the price is too low. The acquirer may have to offer a higher price to get their approval. Or a competing offer is anticipated by the market. The emergence of another suitor could result in a bidding contest, pushing the stock higher and higher.

Midwest Air Group was the subject of a protracted bidding war. Air Tran first bid $4.50 a share for Midwest in late-2006 but met resistance from Midwest’s board. In an effort to consummate the deal, Air Tran upped its bid several times. Then, in a surprise development, private equity firm TPG Capital made a $16.00 cash bid in August 2007. Air Tran responded with a $16.25 cash and stock offer. Just days later, Midwest’s board announced that it had unanimously approved a sweetened TPG’s all cash offer of $17.00 a share. News of Northwest’s proposed sale to Delta Airlines clouded expectations for a timely close but TPG completed the transaction in late January 2008, ending a nearly two year bidding war.

There have been losses. The leveraged buyout of SLM Corporation (SLM) by JC Flowers, a private equity fund, fell apart soon after Congress passed legislation in late 2007 lowering the rates lenders could charge on student loans. JC cited the legislation as constituting a material adverse event or “MAE” and withdrew its $60 offer. The stock price unraveled along with the deal and recently traded near $10 a share.

With many deals wrapping up in less than a year, most gains or losses will be short-term. This makes tax-deferred retirement accounts, like IRAs, better suited for participating in cash tender offers than taxable accounts.

In spite of some spectacular failures, most tender offers have been successful. Intrepid investors may want to consider participating in a handful of cash tender offer situations. After a promising start, we unwound our positions in late 2008 after realizing substantial losses during the market crisis.

Its over and we get 850 like it or not, mgt and institutions will do very well at the expense of small shareholders...same old story ... I do hope some form of justice (God, Karma, Cosmic) eventually hits mgt and BODs hard. Nothing left to do except to wait for the 850 pps to hit my acct. Lawyers will get paid togo away and a crumb will given to the retail investor to share to make everything legal.

Greatceasarsghost/Harlem/Others-

If you really think the PPS will go off at $ 8.50, then why don't you sell right now when the SP has been in the 8.50's & 8.60's? One would think you would want to optimize your profits, if you think $ 8.50 is all your going to get that's fine, but I would certainly not sleep well knowing what has happened today and going forward.

Remember, all it would take is one bidder to come in and it would change the whole dynamic. It's why the smart thing would be to wait this thing out and see what happens. Regardless of what one chooses, I wish the best to everyone!